cdmo.directory
← Compare landing

Advaxia vs Synthego

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAdvaxiaSynthego
SummarycGMP CDMO specializing in adenovirus vaccine development and manufacturing with a 100% batch approval rate and 10+ years of biologics expertise, serving major pharmaceutical and biotech clients.Synthego manufactures GMP-grade CRISPR components and molecular biology reagents for clinical and research applications, with 19 INDs cleared and 200+ clinical sgRNA batches produced.
Services
  • Cell-Line Development
  • Viral Vector Manufacturing
  • Vaccine Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Gene Therapy
  • Vaccine
  • Cell Therapy
  • Gene Therapy
Development capabilities
  • Analytical method development
  • Cell line development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Viral Vector
  • Drug Substance (DS)
  • Expression: Cell-Free
Locations
  • Headquarters & Manufacturing Facility, Rome, Lazio, Italy
Data not yet provided.
Certifications
  • EMA · Identifier: EMA compliant
  • FDA · Identifier: FDA compliant
  • AIFA · Identifier: AIFA compliant
  • ISO · Identifier: ISO 14.001
  • ISO · Identifier: ISO 45.001
Data not yet provided.

Find similar companies

Advaxia alternatives · Synthego alternatives

Markdown mirror: /compare/advaxia/synthego.md